Centennial Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Centennial Bank's BMY Position: Q3 2026 in Review
Centennial Bank held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 9,469 shares worth $591K. The position accounts for 0.18% of the portfolio, ranked #89.
Centennial Bank first reported a position in BMY in Q4 2022 and has held it in 16 quarters since. The position peaked at $954K in Q4 2022. 2,524 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Centennial Bank held 9,469 shares of Bristol-Myers Squibb worth $591K as of Q3 2026.
- Centennial Bank left its Bristol-Myers Squibb share count unchanged in Q3 2026.
- Bristol-Myers Squibb made up 0.18% of Centennial Bank's portfolio in Q3 2026, its #89 holding.
- Centennial Bank first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 16 quarters since.
- Centennial Bank's Bristol-Myers Squibb position peaked at $954K in Q4 2022.
- 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Centennial Bank's 13F filing for Q3 2026, filed 9 Nov 2026.